When drugs are administered extravascularly, a comprehensive evaluation through noncompartmental analysis becomes imperative. This analytical approach considers various parameters that play a crucial role in understanding the pharmacokinetics of these drugs.

One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area under the concentration-time curve. Doing so provides valuable insights into the drug's mean absorption time (MAT) to reach the systemic circulation and its mean residence time (MRT) within the systemic circulation.

It is worth noting that regardless of the administration route, the mean residence time remains constant. However, the MRT significantly influences the drug's mean absorption and transit times. This observation underscores the importance of considering the residence time when analyzing the pharmacokinetic behavior of extravascularly administered drugs.

In the case of orally administered tablets or capsules, an additional parameter called mean dissolution time (MDT) comes into play. MDT explicitly evaluates the time required for the drug to dissolve in vivo. Its estimation is straightforward for immediate-release-type products, as they exhibit predictable dissolution patterns. In extended-release (ER) formulations, the release of the drug is controlled by various mechanisms, such as matrix systems, coatings, or osmotic pumps, which extend the dissolution process. The extended-release directly increases the MDT compared to immediate-release (IR) formulations.

To calculate the mean dissolution time, we must determine the difference between the mean transit time for a solution and the mean transit time for an immediate-release solid drug product. This distinction provides a valuable indication of the drug's dissolution characteristics and aids in understanding its behavior within the body.

By applying noncompartmental analysis and considering these parameters, researchers and healthcare professionals can understand how extravascularly administered drugs interact with the body, including their transit, absorption, residence, and dissolution processes. This knowledge enables them to make informed decisions regarding dosing regimens, therapeutic efficacy, and potential drug interactions.

장에서 7:

article

Now Playing

7.28 : Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time

Pharmacokinetic Models

14 Views

article

7.1 : 약동학 데이터의 분석 방법: 모델 및 모델 독립적 접근 방식

Pharmacokinetic Models

26 Views

article

7.2 : 약동학 데이터에 대한 모델 접근법: 구획 모델

Pharmacokinetic Models

17 Views

article

7.3 : IV 볼루스 투여를 위한 One-Compartment Open Model: 일반적인 고려 사항

Pharmacokinetic Models

37 Views

article

7.4 : IV 볼루스 투여를 위한 One-compartment open model: 제거율 상수, 반감기 및 분포량 추정

Pharmacokinetic Models

19 Views

article

7.5 : IV 볼루스 투여를 위한 One-compartment open 모델: 청소율 추정

Pharmacokinetic Models

16 Views

article

7.6 : 1격실 모델: IV 주입

Pharmacokinetic Models

57 Views

article

7.7 : 혈관외 투여를 위한 One-compartment open model: zero-order absorption 모델

Pharmacokinetic Models

12 Views

article

7.8 : 혈관외 투여를 위한 One-compartment open model: First-Order Absorption 모델

Pharmacokinetic Models

57 Views

article

7.9 : 1구획 개방 모델: ka 추정을 위한 Wagner-Nelson 및 Loo Riegelman 방법

Pharmacokinetic Models

71 Views

article

7.10 : One-Compartment Open Model: 비뇨기 배설 데이터 및 k의 결정

Pharmacokinetic Models

19 Views

article

7.11 : Multicompartment 모델: 개요

Pharmacokinetic Models

9 Views

article

7.12 : Two-Compartment Open 모델: 개요

Pharmacokinetic Models

30 Views

article

7.13 : 2격실 개방형 모델: IV 볼루스 투여

Pharmacokinetic Models

68 Views

article

7.14 : 2 격실 개방형 모델 : IV 주입

Pharmacokinetic Models

61 Views

See More

JoVE Logo

개인 정보 보호

이용 약관

정책

연구

교육

JoVE 소개

Copyright © 2025 MyJoVE Corporation. 판권 소유